Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2013

01-03-2013 | Original Article

Non-Adherence and Graft Failure in Adult Liver Transplant Recipients

Authors: Sarah R. Lieber, Michael L. Volk

Published in: Digestive Diseases and Sciences | Issue 3/2013

Login to get access

Abstract

Background

Non-adherence to medical therapy after liver transplantation is confounded by different methods of measurement.

Aims

(1) To compare the performance of three different methods of measuring non-adherence: (a) biochemical (standard deviation [SD] tacrolimus levels), (b) clinician report, (c) self-report. (2) To identify pre-transplant predictors of post-transplant non-adherence. (3) To evaluate whether SD tacrolimus is an accurate predictor of graft outcomes.

Methods

In this retrospective cohort study, charts of adult recipients of a liver transplant 2003–2009 (sample A, n = 444) were reviewed to determine pre-transplant predictors of non-adherence and clinician report of non-adherence. SD tacrolimus levels were measured between 6 and 18 months post-transplant. A subset of sample A (n = 122) completed a survey on non-adherence. The three methods were compared using linear and logistic regression. Multivariable analysis was used to investigate pre-transplant predictors of non-adherence. In sample B (transplant recipients 1995–2003, n = 544) Cox regression was used to determine the relationship between SD immunosuppressant level and graft failure.

Results

Non-adherence was found in 22–62 % of subjects, with the highest rates indicated by self-report. Clinician report of non-adherence was associated with both self-report and SD tacrolimus. On multivariable analysis, unemployment at time of listing and chart evidence of pre-transplant non-adherence were significant predictors of higher SD of tacrolimus. History of substance abuse and pre-transplant chart evidence of non-adherence were also significant independent predictors of post-transplant chart evidence of non-adherence. Drug variability in the immediate post-transplant setting was independently associated with graft failure over time (hazard ratio 1.005 per unit increase in standard deviation, p = 0.04).

Conclusions

Non-adherence among liver transplant recipients is a common problem associated with increased risk of graft failure. SD tacrolimus can be used to measure non-adherent behavior and perhaps target patients for behavioral interventions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Trans Proc. 2007;39:3169–3174.CrossRef Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Trans Proc. 2007;39:3169–3174.CrossRef
2.
go back to reference Volk M. Personal communication. In: Lieber S, ed. City; 2010. Volk M. Personal communication. In: Lieber S, ed. City; 2010.
3.
go back to reference Aranda-Michel J, Dickson RC, Bonatti H, Crossfield JR, Keaveny AP, Vasquez AR. Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clinic Proc. 2008;83:165–168. Aranda-Michel J, Dickson RC, Bonatti H, Crossfield JR, Keaveny AP, Vasquez AR. Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clinic Proc. 2008;83:165–168.
4.
go back to reference Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59:13–20.PubMedCrossRef Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59:13–20.PubMedCrossRef
5.
go back to reference Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Trans Int. 2005;18:1121–1133.CrossRef Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Trans Int. 2005;18:1121–1133.CrossRef
6.
go back to reference Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858–873.PubMedCrossRef Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858–873.PubMedCrossRef
7.
go back to reference Lisson GL, Rodrigue JR, Reed AI, Nelson DR. A brief psychological intervention to improve adherence following transplantation. Ann Trans. 2005;10:52–57. Lisson GL, Rodrigue JR, Reed AI, Nelson DR. A brief psychological intervention to improve adherence following transplantation. Ann Trans. 2005;10:52–57.
8.
go back to reference Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Trans. 2004;8:233–236.CrossRef Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Trans. 2004;8:233–236.CrossRef
9.
go back to reference Stuber ML, Shemesh E, Seacord D, Washington J III, Hellemann G, McDiarmid S. Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Trans. 2008;12:284–288.CrossRef Stuber ML, Shemesh E, Seacord D, Washington J III, Hellemann G, McDiarmid S. Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Trans. 2008;12:284–288.CrossRef
10.
go back to reference Venkat VL, Nick TG, Bucuvalas JC, Wang Y. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Trans. 2008;12:67–72.CrossRef Venkat VL, Nick TG, Bucuvalas JC, Wang Y. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Trans. 2008;12:67–72.CrossRef
11.
go back to reference Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics. 2004;113:825–832.PubMedCrossRef Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics. 2004;113:825–832.PubMedCrossRef
12.
go back to reference Morales JM, Varo E, Lazaro P. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transpl. 2012;26:369–376.CrossRef Morales JM, Varo E, Lazaro P. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transpl. 2012;26:369–376.CrossRef
13.
go back to reference Drent G, Haagsma EB, Geest SD, et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients. Transpl Int. 2005;18:960–966.PubMedCrossRef Drent G, Haagsma EB, Geest SD, et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients. Transpl Int. 2005;18:960–966.PubMedCrossRef
14.
go back to reference Lamba S, Nagurka R, Desai KK, Chun SJ, Holland B, Koneru B. Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transpl. 2012;26:328–335.CrossRef Lamba S, Nagurka R, Desai KK, Chun SJ, Holland B, Koneru B. Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transpl. 2012;26:328–335.CrossRef
15.
go back to reference Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transpl. 2009;9:35–41.CrossRef Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transpl. 2009;9:35–41.CrossRef
16.
17.
go back to reference Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497–1504.PubMedCrossRef Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497–1504.PubMedCrossRef
18.
go back to reference Chisholm MA. Enhancing transplant patients’ adherence to medication therapy. Clin Transpl. 2002;16:30–38.CrossRef Chisholm MA. Enhancing transplant patients’ adherence to medication therapy. Clin Transpl. 2002;16:30–38.CrossRef
19.
go back to reference Drent G, De Geest S, Haagsma EB. Prednisolone noncompliance and outcome in liver transplant recipients. Transpl Int. 2006;19:342–343.PubMedCrossRef Drent G, De Geest S, Haagsma EB. Prednisolone noncompliance and outcome in liver transplant recipients. Transpl Int. 2006;19:342–343.PubMedCrossRef
20.
go back to reference Telles-Correia D, Barbosa A, Mega I, Monteiro E. Psychosocial predictors of adherence after liver transplant in a single transplant center in Portugal. Prog Transpl. 2012;22:91–94.CrossRef Telles-Correia D, Barbosa A, Mega I, Monteiro E. Psychosocial predictors of adherence after liver transplant in a single transplant center in Portugal. Prog Transpl. 2012;22:91–94.CrossRef
21.
go back to reference Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation. 2012;93:958–963.PubMedCrossRef Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation. 2012;93:958–963.PubMedCrossRef
22.
go back to reference Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–172.PubMedCrossRef Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–172.PubMedCrossRef
23.
go back to reference Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417–1426.PubMedCrossRef Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417–1426.PubMedCrossRef
24.
go back to reference O’Carroll RE, McGregor LM, Swanson V, Masterton G, Hayes PC. Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl. 2006;12:1862–1868.PubMedCrossRef O’Carroll RE, McGregor LM, Swanson V, Masterton G, Hayes PC. Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl. 2006;12:1862–1868.PubMedCrossRef
26.
go back to reference Telles-Correia D, Barbosa A, Mega I, Monteiro E. Adherence correlates in liver transplant candidates. Transpl Proc. 2009;41:1731–1734.CrossRef Telles-Correia D, Barbosa A, Mega I, Monteiro E. Adherence correlates in liver transplant candidates. Transpl Proc. 2009;41:1731–1734.CrossRef
27.
go back to reference Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transpl. 2008;8:616–626.CrossRef Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transpl. 2008;8:616–626.CrossRef
28.
go back to reference Beckebaum S, Iacob S, Sweid D, et al. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24:666–675.PubMedCrossRef Beckebaum S, Iacob S, Sweid D, et al. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24:666–675.PubMedCrossRef
29.
go back to reference Dharancy S, Giral M, Tetaz R, Fatras M, Dubel L, Pageaux GP. Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin Transpl. 2012;26:E293–E299.CrossRef Dharancy S, Giral M, Tetaz R, Fatras M, Dubel L, Pageaux GP. Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin Transpl. 2012;26:E293–E299.CrossRef
30.
go back to reference Merli M, Di Menna S, Giusto M, et al. Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. Transpl Proc. 2010;42:1322–1324.CrossRef Merli M, Di Menna S, Giusto M, et al. Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. Transpl Proc. 2010;42:1322–1324.CrossRef
31.
go back to reference Stilley CS, DiMartini AF, de Vera ME, et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Prog Transpl. 2010;20:58–66; quiz 67. Stilley CS, DiMartini AF, de Vera ME, et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Prog Transpl. 2010;20:58–66; quiz 67.
32.
go back to reference De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009;22:780–797.PubMedCrossRef De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009;22:780–797.PubMedCrossRef
Metadata
Title
Non-Adherence and Graft Failure in Adult Liver Transplant Recipients
Authors
Sarah R. Lieber
Michael L. Volk
Publication date
01-03-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2412-0

Other articles of this Issue 3/2013

Digestive Diseases and Sciences 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine